id stringlengths 9 11 | source stringclasses 1
value | title stringlengths 15 560 | text stringlengths 2k 153k |
|---|---|---|---|
PMC9545191 | core_pubmed_pmc | Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus | Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus Abstract Abstract Dapagliflozin improves glycemic control in patients with type 2 diabetes mellitus (T2DM) and is approved in Japanese patients with type 1 diabetes mellitus (T1DM) with inadequate glycemic control. The objectiv... |
PMC9045325 | core_pubmed_pmc | Fluconazole Population Pharmacokinetics after Fosfluconazole Administration and Dosing Optimization in Extremely Low-Birth-Weight Infants | Fluconazole Population Pharmacokinetics after Fosfluconazole Administration and Dosing Optimization in Extremely Low-Birth-Weight Infants Abstract ABSTRACT A prospective single-center study was conducted to characterize the pharmacokinetics (PK) of fluconazole (FLCZ) in extremely low-birth-weight infants (ELBWIs) who r... |
PMC6704567 | core_pubmed_pmc | Anti-PD-1 monoclonal antibody MEDI0680 in a phase I study of patients with advanced solid malignancies | Anti-PD-1 monoclonal antibody MEDI0680 in a phase I study of patients with advanced solid malignancies Abstract Background The safety, efficacy, pharmacokinetics, and pharmacodynamics of the anti-programmed cell death-1 antibody MEDI0680 were evaluated in a phase I, multicenter, dose-escalation study in advanced solid ... |
PMC7894400 | core_pubmed_pmc | Population pharmacokinetic model with time‐varying clearance for lorlatinib using pooled data from patients with non‐small cell lung cancer and healthy participants | Population pharmacokinetic model with time‐varying clearance for lorlatinib using pooled data from patients with non‐small cell lung cancer and healthy participants Abstract Abstract Lorlatinib, a selective inhibitor of anaplastic lymphoma kinase (ALK) and c‐ROS oncogene 1 (ROS1) tyrosine kinase, is indicated for the t... |
PMC9474582 | core_pubmed_pmc | Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1 | Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1 Abstract Abstract Purpose Bintrafusp alfa (BA) is a bifunctional fusion protein composed of the extracellular domain of the transforming growth factor-β (TGF-β) receptor II fus... |
PMC10020863 | core_pubmed_pmc | Project Optimus, an FDA initiative: Considerations for cancer drug development internationally, from an academic perspective | Project Optimus, an FDA initiative: Considerations for cancer drug development internationally, from an academic perspective Abstract Modern cancer therapeutics are increasingly targeted, bringing the promise of new and improved activity, alongside better tolerability. However, while many are indeed resulting in dramat... |
PMC8663962 | core_pubmed_pmc | Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions | Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions Abstract Abstract This article summarizes the current literature and documents new evidence concerning drug-drug interactions (DDI) stemming from pharmacogenomic and circadian rhythm determinants of therapies used to treat comm... |
PMC6539080 | core_pubmed_pmc | Simultaneous Determination and Pharmacokinetic Characterization of Glycyrrhizin, Isoliquiritigenin, Liquiritigenin, and Liquiritin in Rat Plasma Following Oral Administration of Glycyrrhizae Radix Extract | Simultaneous Determination and Pharmacokinetic Characterization of Glycyrrhizin, Isoliquiritigenin, Liquiritigenin, and Liquiritin in Rat Plasma Following Oral Administration of Glycyrrhizae Radix Extract Abstract Abstract Glycyrrhizae Radix is widely used as herbal medicine and is effective against inflammation, vario... |
PMC9695821 | core_pubmed_pmc | Synthesis and Evaluation of NF-κB Inhibitory Activity of Mollugin Derivatives | Synthesis and Evaluation of NF-κB Inhibitory Activity of Mollugin Derivatives Abstract Abstract (1) Background: Nuclear factor κB (NF-κB) is an important transcriptional regulator that regulates the inflammatory pathway and plays a key role in cellular inflammatory and immune responses. The presence of a high concentra... |
PMC11835428 | core_pubmed_pmc | Semimechanistic Population PK/PD Modeling of Axatilimab in Healthy Participants and Patients With Solid Tumors or Chronic Graft‐Versus‐Host Disease | Semimechanistic Population PK/PD Modeling of Axatilimab in Healthy Participants and Patients With Solid Tumors or Chronic Graft‐Versus‐Host Disease Abstract Axatilimab, a high‐affinity humanized immunoglobulin G4 monoclonal antibody against colony‐stimulating factor 1 receptor (CSF‐1R), is approved for the treatment of... |
PMC5351340 | core_pubmed_pmc | The Pharmacokinetic Exposure to Fexofenadine is Volume‐Dependently Reduced in Healthy Subjects Following Oral Administration With Apple Juice | The Pharmacokinetic Exposure to Fexofenadine is Volume‐Dependently Reduced in Healthy Subjects Following Oral Administration With Apple Juice Abstract Abstract Pharmacokinetic exposures to fexofenadine (FEX) are reduced by apple juice (AJ); however, the relationship between the AJ volume and the degree of AJ‐FEX intera... |
PMC8698904 | core_pubmed_pmc | Drug Delivery Challenges in Brain Disorders across the Blood–Brain Barrier: Novel Methods and Future Considerations for Improved Therapy | Drug Delivery Challenges in Brain Disorders across the Blood–Brain Barrier: Novel Methods and Future Considerations for Improved Therapy Abstract Abstract Due to the physiological and structural properties of the blood–brain barrier (BBB), the delivery of drugs to the brain poses a unique challenge in patients with cen... |
PMC10747608 | core_pubmed_pmc | Bovine Serum Albumin Nanoparticles Enhanced the Intranasal Bioavailability of Silybin in Rats | Bovine Serum Albumin Nanoparticles Enhanced the Intranasal Bioavailability of Silybin in Rats Abstract Abstract Silybin (SLB), an important flavonoid from silymarin, displays significant hepatoprotective, anticancer, antioxidant, and neuroprotective effects. However, its therapeutic efficacy is limited by its low solub... |
PMC9405042 | core_pubmed_pmc | Pharmacodynamics of Flucloxacillin in a Neutropenic Murine Thigh Infection Model: A Piece of the Puzzle towards Evidence-Based Dosing | Pharmacodynamics of Flucloxacillin in a Neutropenic Murine Thigh Infection Model: A Piece of the Puzzle towards Evidence-Based Dosing Abstract For decades, flucloxacillin has been used to treat methicillin-susceptible Staphylococcus aureus (MSSA). Little is still known about its pharmacodynamics (PD). The present study... |
PMC5763286 | core_pubmed_pmc | Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model | Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model Abstract Background Drug development considering individual varieties among patients becomes crucial to improve clinical developmen... |
PMC11851067 | core_pubmed_pmc | An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis | An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis Abstract Abstract Metabolic imbalance is associated with amyotrophic lateral sclerosis progression. Impaired glucose oxidation and increased reliance on fatty acid oxidation contribute to r... |
PMC9812024 | core_pubmed_pmc | Prediction of the Contribution Ratio of a Target Metabolic Enzyme to Clearance from Chemical Structure Information | Prediction of the Contribution Ratio of a Target Metabolic Enzyme to Clearance from Chemical Structure Information Abstract Abstract The contribution ratio of metabolic enzymes such as cytochrome P450 to in vivo clearance (fraction metabolized: fm) is a pharmacokinetic index that is particularly important for the quant... |
PMC12002994 | core_pubmed_pmc | Mechanistic intracellular PK/PD modeling to inform development strategies for small interfering RNA therapeutics | Mechanistic intracellular PK/PD modeling to inform development strategies for small interfering RNA therapeutics Abstract Small interfering RNA (siRNA) therapeutics provide a targeted approach to silence disease-related genes, with notable success in liver-targeting applications. However, the quantitative effects of si... |
PMC6430159 | core_pubmed_pmc | Target‐Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy | Target‐Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy Abstract Bispecific antibodies (BsAbs) bind to two different targets, and create two binary and one ternary complex ( TC ). These molecules have shown promise as immuno‐oncology drugs, and the TC is ... |
PMC11416114 | core_pubmed_pmc | Target Attainment and Population Pharmacokinetics of Nirmatrelvir/Ritonavir in Critically Ill Adult Patients | Target Attainment and Population Pharmacokinetics of Nirmatrelvir/Ritonavir in Critically Ill Adult Patients Abstract Background The population pharmacokinetics of nirmatrelvir/ritonavir (NIR/RIT) has not yet been described for critically ill adult patient. Purpose This was a prospective observational population pharma... |
PMC11502913 | core_pubmed_pmc | A phase 1 dose escalation of pritumumab in patients with refractory or recurrent gliomas or brain metastases | A phase 1 dose escalation of pritumumab in patients with refractory or recurrent gliomas or brain metastases Abstract Abstract Background This phase 1 ( NCT04396717 ) open-label, multicenter study, evaluated Pritumumab, a IgG1 monoclonal antibody, in patients with gliomas and brain metastases. The primary objective was... |
PMC11315830 | core_pubmed_pmc | Antibody–Drug Conjugates in the Pipeline for Treatment of Melanoma: Target and Pharmacokinetic Considerations | Antibody–Drug Conjugates in the Pipeline for Treatment of Melanoma: Target and Pharmacokinetic Considerations Abstract Abstract Melanoma is an aggressive, rapidly developing form of skin cancer that affects about 22 per 100,000 individuals. Treatment options for melanoma patients are limited and typically involve surgi... |
PMC10101109 | core_pubmed_pmc | Efficacy of Zidovudine-Amikacin Combination Therapy In Vitro and in a Rat Tissue Cage Infection Model against Amikacin-Resistant, Multidrug-Resistant Enterobacteriales | Efficacy of Zidovudine-Amikacin Combination Therapy In Vitro and in a Rat Tissue Cage Infection Model against Amikacin-Resistant, Multidrug-Resistant Enterobacteriales Abstract ABSTRACT Multidrug-resistant (MDR) Enterobacteriales infections have become an urgent global threat to public health. The aim of this study was... |
PMC8305691 | core_pubmed_pmc | Pharmacokinetics, Biodistribution, and Biosafety of PEGylated Gold Nanoparticles In Vivo | Pharmacokinetics, Biodistribution, and Biosafety of PEGylated Gold Nanoparticles In Vivo Abstract Abstract Despite the obvious advantages of gold nanoparticles for biomedical applications, controversial and incomplete toxicological data hamper their widespread use. Here, we present the results from an in vivo toxicity ... |
PMC9924181 | core_pubmed_pmc | Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study | Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study Abstract Abstract Introduction Risdiplam is a survival of motor neuron 2 ( SMN2 ) splicing modifier for the treatment of patients with spinal muscular atrophy (SMA). The JEWELFISH stud... |
PMC12942462 | core_pubmed_pmc | Envarsus Versus Advagraf in De Novo Kidney Transplant Recipients: A Comparative Pharmacokinetic Study | Envarsus Versus Advagraf in De Novo Kidney Transplant Recipients: A Comparative Pharmacokinetic Study Abstract Abstract Background: Comparative real-world data on the pharmacokinetics of once-daily tacrolimus formulations in de novo kidney transplantation remain limited. We compared tacrolimus exposure and dosing requi... |
PMC8013631 | core_pubmed_pmc | Efficacy and safety of vancomycin loading doses in critically ill patients with methicillin-resistant Staphylococcus aureus infection | Efficacy and safety of vancomycin loading doses in critically ill patients with methicillin-resistant Staphylococcus aureus infection Abstract Background: While vancomycin loading doses may facilitate earlier pharmacokinetic–pharmacodynamic target attainment, the impact of loading doses on clinical outcomes remains und... |
PMC3522110 | core_pubmed_pmc | Pharmacokinetics and Relative Bioavailability of Flavonoids between Two Dosage Forms of Gegen-Qinlian-Tang in Rats | Pharmacokinetics and Relative Bioavailability of Flavonoids between Two Dosage Forms of Gegen-Qinlian-Tang in Rats Abstract Abstract Gegen-Qinlian-Tang (GQT), a popular Chinese medicine prescription, consists of Puerariae Radix, Scutellariae Radix, Coptidis Rhizoma, and Glycyrrhizae Radix. This study investigated the p... |
PMC12964424 | core_pubmed_pmc | Pharmacokinetics and preliminary data on safety of meloxicam subcutaneous extended-release formulation in Sprague–Dawley rats | Pharmacokinetics and preliminary data on safety of meloxicam subcutaneous extended-release formulation in Sprague–Dawley rats Abstract Abstract Introduction Nonsteroidal anti-inflammatory drugs (NSAIDs) play a critical role in managing pain and inflammation in veterinary medicine. Meloxicam, a widely used NSAID, is com... |
PMC9401513 | core_pubmed_pmc | First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors | First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors Abstract Abstract Purpose: We investigated safety, tolerability, pharmacokinetics, and antitumor activity of the protein tyrosine kinase 7 (PTK7)-targeted, auristatin-bas... |
PMC5855550 | core_pubmed_pmc | Pharmacokinetic Study of Bioactive Flavonoids in the Traditional Japanese Medicine Keigairengyoto Exerting Antibacterial Effects against Staphylococcus aureus | Pharmacokinetic Study of Bioactive Flavonoids in the Traditional Japanese Medicine Keigairengyoto Exerting Antibacterial Effects against Staphylococcus aureus Abstract Abstract Recent studies have demonstrated that flavonoid glucuronides can be deconjugated to the active form aglycone by β-glucuronidase-expressing macr... |
PMC7338818 | core_pubmed_pmc | Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study | Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study Abstract Abstract Purpose In this exploratory study, the effect of postprocedural flushing with crystalloids after oxaliplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) on platinum concen... |
PMC12642000 | core_pubmed_pmc | Physiologically Based Pharmacokinetic Model for Prediction of Immunoglobulins Exposure in Pregnant Women | Physiologically Based Pharmacokinetic Model for Prediction of Immunoglobulins Exposure in Pregnant Women Abstract Background : Physiologically based pharmacokinetic (PBPK) modeling is applied to address clinical pharmacology issues including dose selection and exposure assessments for special populations (e.g., pediatr... |
PMC11975176 | core_pubmed_pmc | Lack of Pharmacokinetic Drug–Drug Interactions Between Bepirovirsen and Nucleos(t)ide Analogs | Lack of Pharmacokinetic Drug–Drug Interactions Between Bepirovirsen and Nucleos(t)ide Analogs Abstract Abstract Bepirovirsen is an antisense oligonucleotide currently in Phase 3 development to treat chronic hepatitis B virus (HBV) infection. Given the importance of coadministration of bepirovirsen and standard‐of‐care ... |
PMC10302878 | core_pubmed_pmc | Long-Acting Opioid Analgesics for Acute Pain: Pharmacokinetic Evidence Reviewed | Long-Acting Opioid Analgesics for Acute Pain: Pharmacokinetic Evidence Reviewed Abstract Simple Summary Pharmacokinetic (PK) studies measure the time for a dose of a drug to reach therapeutic levels in a patient’s blood or tissues. This data provides a simple and precise method to compare the response to drugs made by ... |
PMC12353791 | core_pubmed_pmc | Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial | Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial Abstract The angiopoietin-like protein 3/8 complex (ANGPTL3/8) inhibits lipoprotein lipase (LPL) activity, primarily in oxidative tissues, and does so more potently than ANGPTL3, making ... |
PMC6188068 | core_pubmed_pmc | In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance | In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance Abstract Abstract Background Raloxifene hydrochloride (RLX) is approved by the US Food and Drug Administration for the treatment and prevention of osteopo... |
PMC9515533 | core_pubmed_pmc | Initial sirolimus dosage recommendations for pediatric patients with PIK3CD mutation-related immunodeficiency disease | Initial sirolimus dosage recommendations for pediatric patients with PIK3CD mutation-related immunodeficiency disease Abstract Abstract Sirolimus is used to treat pediatric patients with PIK3CD mutation-related immunodeficiency disease. However, the initial dosages of sirolimus remain undecided. The present study aims ... |
PMC8032623 | core_pubmed_pmc | Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro–in vivo extrapolation | Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro–in vivo extrapolation Abstract Abstract Amiodarone is an antiarrhythmic agent inducing adverse effects on the nervous system, among others. We applied physiologically based pharmacokinetic ... |
PMC10700596 | core_pubmed_pmc | Docking for EP4R antagonists active against inflammatory pain | Docking for EP4R antagonists active against inflammatory pain Abstract The lipid prostaglandin E 2 (PGE 2 ) mediates inflammatory pain by activating G protein-coupled receptors, including the prostaglandin E2 receptor 4 (EP4R). Nonsteroidal anti-inflammatory drugs (NSAIDs) reduce nociception by inhibiting prostaglandin... |
PMC12764621 | core_pubmed_pmc | Predicting the toxicity-efficacy ratio of venetoclax in real-world patients | Predicting the toxicity-efficacy ratio of venetoclax in real-world patients Abstract Abstract This study investigates the pharmacokinetic variability and exposure-response relationships of Venetoclax (VEN) in adult patients with acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy. The study was c... |
PMC9805719 | core_pubmed_pmc | Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects | Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects Abstract Abstract Purpose This study was performed to compare the pharmacokinetics of two fixed-dose combination (FDC) formulations of teneligliptin com... |
PMC12868987 | core_pubmed_pmc | Anthelmintic Efficacy of Rosemary Oil and Its Nanoemulsion Against the Monogenean Parasite, Zeuxapta seriolae , in Yellowtail Kingfish ( Seriola lalandi ) | Anthelmintic Efficacy of Rosemary Oil and Its Nanoemulsion Against the Monogenean Parasite, Zeuxapta seriolae , in Yellowtail Kingfish ( Seriola lalandi ) Abstract This study evaluated the anthelmintic efficacy of rosemary oil delivered as a nanoemulsion compared with regular rosemary oil against the monogenean parasit... |
PMC12819339 | core_pubmed_pmc | Enhancement of oral bioavailability of risedronate through xyloglucan rafts | Enhancement of oral bioavailability of risedronate through xyloglucan rafts Abstract Bisphosphonates irritate the stomach and oesophagus and have a very limited absorption. The purpose of this study was to increase risedronate (RDN) oral bioavailability by causing a raft to form in the stomach. The creation of a raft p... |
PMC12304831 | core_pubmed_pmc | Pharmacokinetics of betamethasone in pre‐eclampsia: An in vivo and ex vivo study | Pharmacokinetics of betamethasone in pre‐eclampsia: An in vivo and ex vivo study Abstract Aims To enhance understanding of betamethasone and its metabolites' pharmacokinetics in pregnancy, specifically early‐onset pre‐eclampsia, through a population pharmacokinetic model. Additionally, to investigate the placental meta... |
PMC12397115 | core_pubmed_pmc | Safety and dosimetry of [ 177 Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study | Safety and dosimetry of [ 177 Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study Abstract Purpose NETTER-P, an open-label Phase II study, evaluated the safety a... |
PMC9753331 | core_pubmed_pmc | Comparison of the neuromuscular effects of two infusion rates of rocuronium in anesthetized pigs | Comparison of the neuromuscular effects of two infusion rates of rocuronium in anesthetized pigs Abstract Abstract Background: Neuromuscular blocking agents are frequently administered to pigs used for research. In humans, administration of the drugs is not without risk and may result in accidental awareness under gene... |
PMC3855985 | core_pubmed_pmc | Simultaneous Determination of Volatile Constituents from Acorus tatarinowii Schott in Rat Plasma by Gas Chromatography-Mass Spectrometry with Selective Ion Monitoring and Application in Pharmacokinetic Study | Simultaneous Determination of Volatile Constituents from Acorus tatarinowii Schott in Rat Plasma by Gas Chromatography-Mass Spectrometry with Selective Ion Monitoring and Application in Pharmacokinetic Study Abstract A sensitive and specific gas chromatographic-mass spectrometry with selected ion monitoring (GC-MS/SIM)... |
PMC10230557 | core_pubmed_pmc | Feasibility study of a clinical decision support system for polymedicated patients in primary care | Feasibility study of a clinical decision support system for polymedicated patients in primary care Abstract Abstract Age‐related changes in pharmacokinetics and pharmacodynamics, multimorbidity, frailty, and cognitive impairment represent challenges for drug treatments. Moreover, older adults are commonly exposed to po... |
PMC6835498 | core_pubmed_pmc | Pharmacokinetic Study of Bioactive Glycopeptide from Strongylocentrotus droebachiensis After Intranasal Administration to Rats Using Biomarker Approach | Pharmacokinetic Study of Bioactive Glycopeptide from Strongylocentrotus droebachiensis After Intranasal Administration to Rats Using Biomarker Approach Abstract A glycopeptide fraction (GPF) from internal organs of green sea urchins ( Strongylocentrotus droebachiensis Müller, Strongylocentrotidae) has been reported to ... |
PMC4831541 | core_pubmed_pmc | A Pharmacokinetic and Pharmacodynamic Study on Intravenous Cefazedone Sodium in Patients with Community-acquired Pneumonia | A Pharmacokinetic and Pharmacodynamic Study on Intravenous Cefazedone Sodium in Patients with Community-acquired Pneumonia Abstract Abstract Background: As a time-dependent antibiotic, the time of cefazedone concentration exceeds the minimum inhibitory concentration (MIC) is the key pharmacokinetic-pharmacodynamic (PK-... |
PMC6728954 | core_pubmed_pmc | Safety of an extended-release injectable moxidectin suspension formulation (ProHeart ® 12) in dogs | Safety of an extended-release injectable moxidectin suspension formulation (ProHeart ® 12) in dogs Abstract Abstract Background The safety of ProHeart® 12 (PH 12; extended-release injectable suspension; 10% moxidectin in glyceryl tristearate microspheres) was evaluated in four studies using Beagle dogs and one study us... |
PMC4541546 | core_pubmed_pmc | RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer | RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer Abstract In this study, long-circulating Arg-Gly-Asp (RGD)-modified aclacinomycin A (ACM) liposomes were prepared by thin film hydration method. Their morphology, particle size, encapsulation efficiency, and... |
PMC9819214 | core_pubmed_pmc | Development and Validation of an Efficient and Highly Sensitive Enzyme-Linked Immunosorbent Assay for Alemtuzumab Quantification in Human Serum and Plasma | Development and Validation of an Efficient and Highly Sensitive Enzyme-Linked Immunosorbent Assay for Alemtuzumab Quantification in Human Serum and Plasma Abstract Supplemental Digital Content is Available in the Text. Background: Alemtuzumab is a humanized monoclonal antibody that targets the CD52 glycoprotein express... |
PMC10167634 | core_pubmed_pmc | A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis | A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis Abstract Following infection with Mycobacterium tuberculosis , young children are at high risk of developing severe forms of tuberculosis (TB) disease, including TB meningitis (TBM), w... |
PMC8297997 | core_pubmed_pmc | Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies | Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies Abstract We report here the results of a phase 3 study to assess the efficacy, safety, and tolerability of GC5107, a new 10% liquid intravenous immunoglobulin (IVIG) in preventing serious bacterial ... |
PMC4004401 | core_pubmed_pmc | Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects | Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects Abstract Aim The aim of the study was to evaluate the pharmacokinetics (PK) of inhaled and intravenous (i.v.) fluticasone furoate (FF) in healthy Caucasian, Chinese, Japanese and Korean subj... |
PMC12032411 | core_pubmed_pmc | Acute dose-dependent effects and self-guided titration of continuous N,N- dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants | Acute dose-dependent effects and self-guided titration of continuous N,N- dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants Abstract Abstract N,N -dimethyltryptamine (DMT) is a serotonergic psychedelic that is known for its short-lasting effects when administered intravenou... |
PMC7803377 | core_pubmed_pmc | Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation | Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation Abstract Autologous, CCR5 gene-edited hematopoietic stem and progenitor cell (HSPC) transplantation is a promising strategy for achieving HIV remission. However, only a fraction of HSPCs can be edited ex vivo t... |
PMC11732916 | core_pubmed_pmc | Impact of different parametric Patlak imaging approaches and comparison with a 2-tissue compartment pharmacokinetic model with a long axial field-of-view (LAFOV) PET/CT in oncological patients | Impact of different parametric Patlak imaging approaches and comparison with a 2-tissue compartment pharmacokinetic model with a long axial field-of-view (LAFOV) PET/CT in oncological patients Abstract Abstract Aim The recently introduced Long-Axial-Field-of-View (LAFOV) PET-CT scanners allow for the first-time whole-b... |
PMC5099547 | core_pubmed_pmc | Edoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine | Edoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine Abstract Aims Edoxaban, a novel factor Xa inhibitor, is a substrate of cytochrome P450 3 A4 (CYP3A4) and the efflux transporter P‐glycoprotein (P‐gp). Three edoxaban drug–drug interaction studies examined the effects of P‐gp inhibitors wi... |
PMC12736838 | core_pubmed_pmc | PopPK and PBPK Models Guide Meropenem Dosing in Critically Ill Children with Augmented Renal Clearance | PopPK and PBPK Models Guide Meropenem Dosing in Critically Ill Children with Augmented Renal Clearance Abstract Abstract Background: Meropenem (MEM) is frequently prescribed for the empirical management of severe infections in the pediatric intensive care unit (PICU). Critically ill children exhibit substantial pharmac... |
PMC3733166 | core_pubmed_pmc | Stereoselective binding of chiral drugs to plasma proteins | Stereoselective binding of chiral drugs to plasma proteins Abstract Abstract Chiral drugs show distinct biochemical and pharmacological behaviors in the human body. The binding of chiral drugs to plasma proteins usually exhibits stereoselectivity, which has a far-reaching influence on their pharmacological activities a... |
PMC12520463 | core_pubmed_pmc | Translation of a Human‐Based Malaria‐on‐a‐Chip Phenotypic Disease Model for In Vivo Applications | Translation of a Human‐Based Malaria‐on‐a‐Chip Phenotypic Disease Model for In Vivo Applications Abstract Abstract In 2023 malaria claimed ≈600000 lives, with 90% of those deaths attributed to the Plasmodium falciparum parasite. This resurgence in mortality emphasizes the necessity of adopting alternative models to acc... |
PMC7717654 | core_pubmed_pmc | Incessant Automatic Atrial Tachycardia in a Neonate Successfully Treated with Nadolol and Closely Spaced Doses of Flecainide: A Case Report | Incessant Automatic Atrial Tachycardia in a Neonate Successfully Treated with Nadolol and Closely Spaced Doses of Flecainide: A Case Report Abstract Abstract Supraventricular tachyarrhythmia (SVT) is the most common type of arrhythmia in childhood. Management can be challenging with an associated risk of mortality. A f... |
PMC4748848 | core_pubmed_pmc | Pharmacokinetic/Toxicity Properties of the New Anti-Staphylococcal Lead Compound SK-03-92 | Pharmacokinetic/Toxicity Properties of the New Anti-Staphylococcal Lead Compound SK-03-92 Abstract Abstract Because of the potential of a new anti-staphylococcal lead compound SK-03-92 as a topical antibiotic, a patch, or an orally active drug, we sought to determine its safety profile and oral bioavailability. SK-03-9... |
PMC12291358 | core_pubmed_pmc | Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress | Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress Abstract Abstract To surpass challenges with traditional approaches to treat Rheumatoid arthritis (RA), an improved understanding of molecular-level pathogenesis brought forth targeted therapy with biologics as a great p... |
PMC10459361 | core_pubmed_pmc | Development and Validation of a Novel UHPLC-MS/MS Method for the Quantification of Plinabulin in Plasma and Its Application in a Pharmacokinetic Study with Leukopenic Rats | Development and Validation of a Novel UHPLC-MS/MS Method for the Quantification of Plinabulin in Plasma and Its Application in a Pharmacokinetic Study with Leukopenic Rats Abstract Plinabulin, a new antitumor drug developed from marine natural products that targets microtubules in cancer cells, is currently being teste... |
PMC12609199 | core_pubmed_pmc | Using Machine Learning for the Discovery and Development of Multitarget Flavonoid-Based Functional Products in MASLD | Using Machine Learning for the Discovery and Development of Multitarget Flavonoid-Based Functional Products in MASLD Abstract Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a multifactorial condition requiring multi-target therapeutic strategies beyond traditional single-marker app... |
PMC10614688 | core_pubmed_pmc | The role of radiolabeling in BNCT tracers for enhanced dosimetry and treatment planning | The role of radiolabeling in BNCT tracers for enhanced dosimetry and treatment planning Abstract Abstract Positron emission tomography (PET) and single photon emission computed tomography (SPECT) are potent technologies for non-invasive imaging of pharmacological and biochemical processes in both preclinical and advanc... |
PMC12655440 | core_pubmed_pmc | Potential Modulation of Polygoni Cuspidati Rhizoma et Radix on Breast Cancer Resistance Protein and Marked Alteration on Methotrexate Pharmacokinetics | Potential Modulation of Polygoni Cuspidati Rhizoma et Radix on Breast Cancer Resistance Protein and Marked Alteration on Methotrexate Pharmacokinetics Abstract Abstract Background/Objectives : Polygoni Cuspidati Rhizoma et Radix (PCRR) is an herb and a source of a resveratrol-containing dietary supplement. Breast cance... |
PMC12968486 | core_pubmed_pmc | Pharmacokinetics and Safety of a Single Subcutaneous or Intramuscular Dose of Ketamine in Healthy Horses | Pharmacokinetics and Safety of a Single Subcutaneous or Intramuscular Dose of Ketamine in Healthy Horses Abstract ABSTRACT Pharmacokinetics (PK) of intramuscular (IM) and subcutaneous (SC) ketamine in horses has not been described. This study aimed to evaluate the PK and safety of ketamine and its metabolites after a s... |
PMC8711110 | core_pubmed_pmc | Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole | Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole Abstract Abstract Purpose Proton pump inhibitors (PPIs) are used for the treatment of acid-related disorders. Demands for enhanced stability and faster onset led to the... |
PMC10609725 | core_pubmed_pmc | Challenges in Permeability Assessment for Oral Drug Product Development | Challenges in Permeability Assessment for Oral Drug Product Development Abstract Drug permeation across the intestinal epithelium is a prerequisite for successful oral drug delivery. The increased interest in oral administration of peptides, as well as poorly soluble and poorly permeable compounds such as drugs for tar... |
PMC9155601 | core_pubmed_pmc | Population pharmacokinetics of intravenous cefotaxime indicates that higher doses are required for critically ill children | Population pharmacokinetics of intravenous cefotaxime indicates that higher doses are required for critically ill children Abstract Abstract Background Cefotaxime is frequently used in critically ill children, however pharmacokinetic (PK) studies to support adequate dosing in this patient population are limited. Object... |
PMC8308703 | core_pubmed_pmc | Therapeutic Drug Monitoring of Busulfan in Patients Undergoing Hematopoietic Cell Transplantation: A Pilot Single-Center Study in Taiwan | Therapeutic Drug Monitoring of Busulfan in Patients Undergoing Hematopoietic Cell Transplantation: A Pilot Single-Center Study in Taiwan Abstract Abstract Busulfan has been used as a conditioning regimen in allogeneic hematopoietic cell stem transplantation (HSCT). Owing to a large inter-individual variation in pharmac... |
PMC10157140 | core_pubmed_pmc | Genetic polymorphism related to ethambutol outcomes and susceptibility to toxicity | Genetic polymorphism related to ethambutol outcomes and susceptibility to toxicity Abstract The World Health Organization (WHO) stated that ensuring access to effective and optimal treatment is a key component to eradicate tuberculosis (TB) through the End TB Strategy. Personalized medicine that depends on the genetic ... |
PMC6880852 | core_pubmed_pmc | Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial | Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial Abstract Abstract Objective To evaluate the efficacy and safety of CT-P10, a rituximab biosimilar after a single switch, during a multinational, randomized, double-blind Phase 3 tri... |
PMC3215871 | core_pubmed_pmc | Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea | Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea Abstract Abstract Purpose To investigate whether clinically relevant levels of epigallocatechin gallate (EGCG, a component of green tea) or vitamin C (ascorbic acid) co... |
PMC3513214 | core_pubmed_pmc | Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management | Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management Abstract There is wide individual variability in the pharmacokinetics, pharmacodynamics, and tolerance to anticancer drugs within the same ethnic group and even greater variability among different ethnicities. Pharmacogeno... |
PMC11381276 | core_pubmed_pmc | Preclinical pharmacokinetic studies and prediction of human PK profiles for Deg-AZM, a clinical-stage new transgelin agonist | Preclinical pharmacokinetic studies and prediction of human PK profiles for Deg-AZM, a clinical-stage new transgelin agonist Abstract Introduction Deglycosylated azithromycin (Deg-AZM), a newly developed Class I drug with good therapeutic effects on slow transit constipation, is a small-molecule transgelin agonist that... |
PMC7606183 | core_pubmed_pmc | A modeling informed quantitative approach to salvage clinical trials interrupted due to COVID‐19 | A modeling informed quantitative approach to salvage clinical trials interrupted due to COVID‐19 Abstract Abstract Many ongoing Alzheimer's disease central nervous system clinical trials are being disrupted and halted due to the COVID‐19 pandemic. They are often of a long duration’ are very complex; and involve many st... |
PMC9921003 | core_pubmed_pmc | Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine | Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine Abstract Selenium is an important dietary supplement and an essential trace element incorporated into selenoproteins with growth-modulating properties and cytotoxic... |
PMC11513893 | core_pubmed_pmc | Discovery of Oral Degraders of the ROS1 Fusion Protein with Potent Activity against Secondary Resistance Mutations | Discovery of Oral Degraders of the ROS1 Fusion Protein with Potent Activity against Secondary Resistance Mutations Abstract Abstract The development of therapeutic resistance in the majority of patients limits the long-term benefit of ROS1 inhibitor treatment. On-target mutations of the ROS1 kinase domain confer resist... |
PMC9245605 | core_pubmed_pmc | Nanocrytals-Mediated Oral Drug Delivery: Enhanced Bioavailability of Amiodarone | Nanocrytals-Mediated Oral Drug Delivery: Enhanced Bioavailability of Amiodarone Abstract The aim of this study was to improve the saturation solubility, dissolution profile and oral bioavailability of amiodarone hydrochloride (AMH), a highly lipophilic drug. Stabilizer (Pluronic F-127)-coated AMH nanocrystals (AMH-NCs)... |
PMC9032118 | core_pubmed_pmc | Squalene-Based Nano-Assemblies Improve the Pro-Autophagic Activity of Trehalose | Squalene-Based Nano-Assemblies Improve the Pro-Autophagic Activity of Trehalose Abstract The disaccharide trehalose is a well-established autophagy inducer, but its therapeutic application is severely hampered by its low potency and poor pharmacokinetic profile. Thus, we targeted the rational design and synthesis of tr... |
PMC4846999 | core_pubmed_pmc | Pharmacokinetic comparison of different flubendazole formulations in pigs: A further contribution to its development as a macrofilaricide molecule | Pharmacokinetic comparison of different flubendazole formulations in pigs: A further contribution to its development as a macrofilaricide molecule Abstract Despite the well established ivermectin activity against microfilaria, the success of human filariasis control programmes requires the use of a macrofilaricide comp... |
PMC12208385 | core_pubmed_pmc | Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial | Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial Abstract INTRODUCTION: Ulcerative colitis (UC) is characterized by colonic inflammation, with neutrophils playing a key role in UC activity, prognosis, and response to therapi... |
PMC10517705 | core_pubmed_pmc | Beta-Blockers and Their Current Role in Maternal and Neonatal Health: A Narrative Review of the Literature | Beta-Blockers and Their Current Role in Maternal and Neonatal Health: A Narrative Review of the Literature Abstract Beta-blockers are a class of medications that act on beta-adrenergic receptors and are categorized as cardio-selective and non-selective. They are principally used to treat cardiovascular conditions such ... |
PMC12971278 | core_pubmed_pmc | A Standardized Culture Medium for Comparative Drug Efficacy Evaluation Across Plasmodium and Babesia Species | A Standardized Culture Medium for Comparative Drug Efficacy Evaluation Across Plasmodium and Babesia Species Abstract The discovery of broad-spectrum antiparasitic agents relies on the ability to evaluate drug efficacy under harmonized in vitro conditions across related species. However, current drug screening pipeline... |
PMC9155642 | core_pubmed_pmc | Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria | Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria Abstract Abstract Background Cipargamin (KAE609) is a potent antimalarial in a phase II trial. Here we report efficacy, pharmacokinetics, and resistance marker... |
PMC3584253 | core_pubmed_pmc | Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody | Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody Abstract Canakinumab is a high-affinity human monoclonal anti-interleukin-1β (IL-1β) antibody of the IgG1/κ isotype designed to bind and neutralize the activity of human IL-1β, a pro-inflammatory cytokine. Can... |
PMC3177244 | core_pubmed_pmc | Multimodal Bacteriochlorophyll Theranostic Agent | Multimodal Bacteriochlorophyll Theranostic Agent Abstract Abstract The complimentary ability of different noninvasive imaging technologies with therapeutic modalities can be used in tandem providing high-resolution and highly sensitive imaging of events at the molecular and cellular level providing a means for image-gu... |
PMC12036611 | core_pubmed_pmc | Model-Informed Precision Dosing of Levamlodipine Besylate in Smoking Patients | Model-Informed Precision Dosing of Levamlodipine Besylate in Smoking Patients Abstract Object To quantitatively investigate the influence of various factors, including nicotine, demographics, biochemical index, and genetic polymorphisms of PAHs and drug metabolising enzymes, on the steady-state trough concentrations of... |
PMC3082038 | core_pubmed_pmc | Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid tumors | Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid tumors Abstract Abstract Purpose TSU-68 is a low molecular weight inhibitor of the tyrosine kinases for vascular endothelial growth factor receptor 2, platelet-derived gro... |
PMC3671111 | core_pubmed_pmc | A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers | A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers Abstract Abstract Abstract This Phase I study aimed to assess the potential drug-drug interactions (pha... |
PMC11655785 | core_pubmed_pmc | Effect of bariatric surgery on the pharmacokinetics of drugs used for attention‐deficit hyperactivity disorder—A case series | Effect of bariatric surgery on the pharmacokinetics of drugs used for attention‐deficit hyperactivity disorder—A case series Abstract Abstract Background Changes in gastrointestinal physiology following bariatric surgery may affect the pharmacokinetics of drugs. Data on the impact of bariatric surgery on drugs used for... |
PMC11042421 | core_pubmed_pmc | Quantifying trade-offs between therapeutic efficacy and resistance dissemination for enrofloxacin dose regimens in cattle | Quantifying trade-offs between therapeutic efficacy and resistance dissemination for enrofloxacin dose regimens in cattle Abstract Abstract The use of antimicrobial drugs in food-producing animals increases the selection pressure on pathogenic and commensal bacteria to become resistant. This study aims to evaluate the ... |
PMC6953120 | core_pubmed_pmc | Characterization of a Fiber Bundle-Based Real-Time Ultrasound/Photoacoustic Imaging System and Its In Vivo Functional Imaging Applications | Characterization of a Fiber Bundle-Based Real-Time Ultrasound/Photoacoustic Imaging System and Its In Vivo Functional Imaging Applications Abstract Abstract Photoacoustic (PA) imaging is an attractive technology for imaging biological tissues because it can capture both functional and structural information with satisf... |
PMC11990732 | core_pubmed_pmc | The Molecular Recognition of Lurasidone by Human Serum Albumin: A Combined Experimental and Computational Approach | The Molecular Recognition of Lurasidone by Human Serum Albumin: A Combined Experimental and Computational Approach Abstract Lurasidone (LUR) is an antipsychotic drug whose interaction with human serum albumin (HSA) plays a crucial role in its pharmacokinetic and pharmacodynamic properties. A thorough understanding of L... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.